Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Retained Earnings: 2017-2025

Historic Retained Earnings for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to -$1.3 billion.

  • Puma Biotechnology's Retained Earnings rose 2.77% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year increase of 2.77%. This contributed to the annual value of -$1.3 billion for FY2024, which is 2.25% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Retained Earnings is -$1.3 billion, which was up 0.68% from -$1.3 billion recorded in Q2 2025.
  • Puma Biotechnology's Retained Earnings' 5-year high stood at -$1.3 billion during Q3 2025, with a 5-year trough of -$1.4 billion in Q3 2021.
  • Its 3-year average for Retained Earnings is -$1.3 billion, with a median of -$1.3 billion in 2023.
  • As far as peak fluctuations go, Puma Biotechnology's Retained Earnings fell by 3.71% in 2022, and later climbed by 3.58% in 2025.
  • Over the past 5 years, Puma Biotechnology's Retained Earnings (Quarterly) stood at -$1.4 billion in 2021, then grew by 0.00% to -$1.4 billion in 2022, then rose by 1.58% to -$1.3 billion in 2023, then climbed by 2.25% to -$1.3 billion in 2024, then climbed by 2.77% to -$1.3 billion in 2025.
  • Its Retained Earnings was -$1.3 billion in Q3 2025, compared to -$1.3 billion in Q2 2025 and -$1.3 billion in Q1 2025.